Carbon nanotubes as vaccine scaffolds

被引：53

作者：

Scheinberg, David A. ^{[1
]}

McDevitt, Michael R.

Dao, Tao

Mulvey, J. Justin

Feinberg, Evan

Alidori, Simone

机构：

[1] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, Dept Med, New York, NY 10021 USA

来源：

ADVANCED DRUG DELIVERY REVIEWS | 2013年 / 65卷 / 15期

关键词：

Carbon nanotubes; vaccines; adjuvants; antigen presenting cells; LARGE-SCALE PURIFICATION; T-CELL RESPONSES; CANCER VACCINES; DENDRITIC CELLS; SIDEWALL FUNCTIONALIZATION; IMMUNOLOGICAL ADJUVANTS; DELIVERY-SYSTEMS; GM-CSF; PEPTIDE; IMMUNOTHERAPY;

D O I：

10.1016/j.addr.2013.07.013

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Carbon nanotubes display characteristics that are potentially useful in their development as scaffolds for vaccine compositions. These features include stability in,vivo, lack of intrinsic immunogenicity, low toxicity, and the ability to be appended with multiple copies of antigens. In addition, the particulate nature of carbon nanotubes and their unusual properties of rapid entry into antigen-presenting cells, such as dendritic cells, make them especially useful as carriers of antigens. Early attempts demonstrating carbon nanotube-based vaccines can be used in both infectious disease settings and cancer are promising. (C) 2013 Elsevier B.V. All rights reserved.

引用

收藏

页码：2016 / 2022

页数：7

相关论文

共 105 条

[91] Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909 [J].

Speiser, DE ;

Liénard, D ;

Rufer, N ;

Rubio-Godoy, V ;

Rimoldi, D ;

Lejeune, F ;

Krieg, AM ;

Cerottini, JC ;

Romero, P .

JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (03) :739-746

[92] Heat shock proteins come of age: Primitive functions acquire new roles in an adaptive world [J].

Srivastava, PK ;

Menoret, A ;

Basu, S ;

Binder, RJ ;

McQuade, KL .

IMMUNITY, 1998, 8 (06) :657-665

[93] TLR-based immune adjuvants [J].

Steinhagen, Folkert ;

Kinjo, Takeshi ;

Bode, Christian ;

Klinman, Dennis M. .

VACCINE, 2011, 29 (17) :3341-3355

[94] Taking dendritic cells into medicine [J].

Steinman, Ralph M. ;

Banchereau, Jacques .

NATURE, 2007, 449 (7161) :419-426

[95] Type I interferon-mediated stimulation of T cells by CgG DNA [J].

Sun, SQ ;

Zhang, XH ;

Tough, DF ;

Sprent, J .

JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (12) :2335-2342

[96]

Teo KBK., 2003, Encycl Nanosci Nanotechnol, V10, P1

[97] Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming [J].

Valmori, Danila ;

Souleimanian, Naira E. ;

Tosello, Valeria ;

Bhardwaj, Nina ;

Adams, Sylvia ;

O'Neill, David ;

Pavlick, Anna ;

Escalon, Juliet B. ;

Cruz, Crystal M. ;

Angiulli, Angelica ;

Angiulli, Francesca ;

Mears, Gregory ;

Vogel, Susan M. ;

Pan, Linda ;

Jungbluth, Achim A. ;

Hoffmann, Eric W. ;

Venhaus, Ralph ;

Ritter, Gerd ;

Old, Lloyd J. ;

Ayyoub, Maha .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (21) :8947-8952

[98] Single-Walled Carbon Nanotubes Deliver Peptide Antigen into Dendritic Cells and Enhance IgG Responses to Tumor-Associated Antigens [J].

Villa, Carlos H. ;

Dao, Tao ;

Ahearn, Ian ;

Fehrenbacher, Nicole ;

Casey, Emily ;

Rey, Diego A. ;

Korontsvit, Tatyana ;

Zakhaleva, Victoriya ;

Batt, Carl A. ;

Philips, Mark R. ;

Scheinberg, David A. .

ACS NANO, 2011, 5 (07) :5300-5311

[99] Vaccinology at the beginning of the 21st century [J].

Wack, A ;

Rappuoli, R .

CURRENT OPINION IN IMMUNOLOGY, 2005, 17 (04) :411-418

[100] Antiviral Role of Toll-Like Receptor-3 Agonists Against Seasonal and Avian Influenza Viruses [J].

Wong, J. P. ;

Christopher, M. E. ;

Viswanathan, S. ;

Dai, X. ;

Salazar, A. M. ;

Sun, L. -Q. ;

Wang, M. .

CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (11) :1269-1274

← 2 3 4 5 6 7 8 9 10 11 →